Human IL-17/IL-17A (Research Grade Secukinumab Biosimilar) Alexa Fluor® 405-conjugated Antibody
Human IL-17/IL-17A (Research Grade Secukinumab Biosimilar) Alexa Fluor® 405-conjugated Antibody Summary
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Reconstitution Calculator
Preparation and Storage
Background: IL-17/IL-17A
Secukinumab is a humanized monoclonal IgG1/k antibody against proinflammatory cytokine IL-17A, and is approved for the treatment of plaque psoriasis, as well as enthesitis-related arthritis, and ankylosing spondylitis. Secukinumab binds to IL-17A with high specificity preventing the interaction with the IL-17 receptor and subsequent activation of the pathway leading to inflammation seen in these disease states. Data has shown that in the presence of secukinumab results in enhanced levels of free unbound IL-17A in the serum indicating inhibition of binding to IL-17A receptor resulting in reduced inflammation.
Product Datasheets
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human IL-17/IL-17A (Research Grade Secukinumab Biosimilar) Alexa Fluor® 405-conjugated Antibody
There are currently no reviews for this product. Be the first to review Human IL-17/IL-17A (Research Grade Secukinumab Biosimilar) Alexa Fluor® 405-conjugated Antibody and earn rewards!
Have you used Human IL-17/IL-17A (Research Grade Secukinumab Biosimilar) Alexa Fluor® 405-conjugated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
